Myocarditis After COVID-19 Third Booster Vaccine in Israel.
作者信息
Mevorach Dror, Anis Emilia, Cedar Noa, Hasin Tal, Bromberg Michal, Goldberg Lital, Levi Nir, Perzon Ofer, Magadle Nur, Barhoum Barhoum, Parnassa Elchanan, Dichtiar Rita, Hershkovitz Yael, Green Manfred S, Ash Nachman, Keinan-Boker Lital, Alroy-Preis Sharon
机构信息
Pnimit B & Division of Rheumatology-Immunology-Allergology and the Wohl Institute for Translational Medicine, Department of Medicine, Hadassah Medical Center, Jerusalem, Israel (D.M., O.P., N.M., B.B., E.P.).
Faculty of Medicine, Hebrew University, Jerusalem, Israel (D.M., E.A., T.H.).
出版信息
Circulation. 2022 Sep 6;146(10):802-804. doi: 10.1161/CIRCULATIONAHA.122.060961.
Abstract
摘要
相似文献
1
Myocarditis After COVID-19 Third Booster Vaccine in Israel.
Circulation. 2022 Sep 6;146(10):802-804. doi: 10.1161/CIRCULATIONAHA.122.060961.
2
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
N Engl J Med. 2022 Nov 10;387(19):1816-1817. doi: 10.1056/NEJMc2207270. Epub 2022 Oct 19.
3
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.
4
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
N Engl J Med. 2022 Jan 27;386(4):399-401. doi: 10.1056/NEJMc2117385. Epub 2021 Dec 22.
5
Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
JAMA. 2022 Apr 12;327(14):1324. doi: 10.1001/jama.2022.4582.
6
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
N Engl J Med. 2022 Mar 10;386(10):998-999. doi: 10.1056/NEJMc2116999. Epub 2022 Jan 26.
7
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.
8
Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
JAMA. 2022 Apr 26;327(16):1611-1612. doi: 10.1001/jama.2022.4425.
9
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
JAMA. 2022 Jan 25;327(4):331-340. doi: 10.1001/jama.2021.24110.
10
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.
引用本文的文献
1
Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients.
J Nucl Med. 2025 Jul 1;66(7):1126-1134. doi: 10.2967/jnumed.124.268980.
2
Pfizer COVID19 vaccine is not associated with acute cardiovascular events excluding myocarditis- a national self-controlled case series study.
Isr J Health Policy Res. 2024 Apr 24;13(1):23. doi: 10.1186/s13584-024-00609-9.
3
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic.
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125549. doi: 10.1016/j.vaccine.2023.12.059. Epub 2024 Feb 9.
4
COVID-19 Boosters: If The US Had Matched Israel's Speed And Take-Up, An Estimated 29,000 US Lives Would Have Been Saved.
Health Aff (Millwood). 2023 Dec;42(12):1747-1757. doi: 10.1377/hlthaff.2023.00718.
5
Side effects of COVID-19 vaccines in the middle eastern population.
Front Immunol. 2023 Nov 3;14:1270187. doi: 10.3389/fimmu.2023.1270187. eCollection 2023.
6
Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS-CoV-2 in the endemic phase?
Eur J Clin Invest. 2023 Feb;53(2):e13906. doi: 10.1111/eci.13906. Epub 2022 Nov 24.
7
Acute perimyocarditis following heterologous vaccination of CoronaVac and BNT162b2 SARS-CoV-2 vaccine in an elderly woman.
J Geriatr Cardiol. 2022 Oct 28;19(10):785-787. doi: 10.11909/j.issn.1671-5411.2022.10.007.
本文引用的文献
1
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
N Engl J Med. 2022 Mar 10;386(10):998-999. doi: 10.1056/NEJMc2116999. Epub 2022 Jan 26.
2
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses.
Cell Host Microbe. 2022 Jan 12;30(1):97-109.e5. doi: 10.1016/j.chom.2021.12.004. Epub 2021 Dec 3.
3
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.
4
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.
5
Advances in mRNA Vaccines for Infectious Diseases.
Front Immunol. 2019 Mar 27;10:594. doi: 10.3389/fimmu.2019.00594. eCollection 2019.
Zotero 插件